AbbVie Sees Unusual Put Volume Sweep as Bears Target $265 Strike Ahead of November Expiry

By TrendSpider Editor

The forward setup for ABBV is worth watching carefully heading into late October and November. The $265 strike represents a level that was last tested earlier in 2026 as the stock climbed from its 52-week low of $191.00. If macro headwinds or sector-level pressures emerge over the next four weeks, t

AbbVie Sees Unusual Put Volume Sweep as Bears Target $265 Strike Ahead of November Expiry

AbbVie Inc. (ABBV) is drawing attention from options traders today, with six unusual put contracts totaling $1,323,470 in combined premium flooding the tape as the stock trades at $284.98, up just 0.09% on the session. All contracts are out of the money and concentrated at the $265 strike expiring November 20, 2026, signaling that some market participants are positioning for a meaningful pullback over the next four weeks. With ABBV trading near the upper end of its 52-week range of $191.00 to $291.33, the bearish positioning stands out against an otherwise resilient price trend.

Key Drivers of the ABBV Stock Move

The forward setup for ABBV is worth watching carefully heading into late October and November. The $265 strike represents a level that was last tested earlier in 2026 as the stock climbed from its 52-week low of $191.00. If macro headwinds or sector-level pressures emerge over the next four weeks, that zone could become a meaningful technical reference point. Pharmaceutical names broadly have faced scrutiny around pricing policy and pipeline risk, and any catalyst that pressures the broader sector could accelerate a move toward the levels these put buyers are targeting. Traders should monitor whether additional put flow accumulates at these strikes in coming sessions, as a sustained buildup would reinforce the bearish thesis implied by today's unusual activity.

ABBV Unusual Options Activity

All six unusual contracts today were puts, with no calls flagged. The activity split across two strikes, both expiring November 20, 2026:

The $265 strike dominated the flow with five separate prints and a combined size of 3,661 contracts. The extreme open interest percentages across every contract confirm these are new positions rather than existing interest being traded, reinforcing the conviction behind the bearish positioning.

ABBV Seasonality

Late October and November have historically been an active period for pharmaceutical stocks, as third-quarter earnings season and year-end portfolio rebalancing can create elevated volatility. Options positioning ahead of November expiration in large-cap biopharma names often reflects either earnings hedging or macro-driven defensive positioning.

ABBV Relative Performance

ABBV is trading at $284.98 today, representing a gain of 0.09% on the session and positioning the stock approximately 49% above its 52-week low of $191.00. The stock remains within roughly 2.2% of its 52-week high of $291.33, suggesting that on a relative basis, ABBV has been a strong performer over the past year. The concentration of bearish options flow at strikes well below the current price, however, suggests some sophisticated participants are beginning to hedge against or bet on a reversal from these elevated levels.

More on ABBV

Latest Market News